Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
An update from C-Rad AB Class B ( ($SE:CRAD.B) ) is now available.
C-RAD has announced its medium-term financial targets, aiming for an average organic growth of over 10% and an operating margin of 25%. The company plans to return at least 30% of net profit to shareholders. Their strategy includes increasing market share, product innovation, and enhancing service offerings to build a resilient and profitable business, which will be detailed further in their upcoming presentation.
More about C-Rad AB Class B
C-RAD is a company specializing in surface-guided imaging solutions for radiation therapy. Their technology focuses on delivering precise radiation doses to tumors while protecting healthy tissue, utilizing high-speed 3D cameras and augmented reality for patient setup and motion monitoring. C-RAD aims to enhance patient safety and comfort without additional imaging doses.
Average Trading Volume: 46,979
Current Market Cap: SEK1.03B
Learn more about CRAD.B stock on TipRanks’ Stock Analysis page.